Company Financials

ResMed Inc. Financials

United States dollar

business ResMed Inc. Company Profile

Main Stock Listing

NYSE: RMD

Market Capitalization $35.73 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 24.65
Forward PE 20.03
Price to Sales TTM $6.69
Price to Book MRQ $5.74
Enterprise to Revenue 6.59
Enterprise to EBITDA 17.86

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2021-06-30
Most Recent Quarter 2025-09-30
Profit Margin 27.35%
Operating Margin 34.62%
Return on Assets TTM 14.19%
Return on Equity TTM 25.41%

Income Statement

Revenue TTM $5,257,399,808
Revenue per Share TTM $35.88
Quarterly Revenue Growth 9.10%
Gross Profit TTM $3,190,838,016
EBITDA $2,020,040,000
Net Income to Common TTM $1,437,904,000
Diluted EPS TTM $9.77
Quarterly Earnings Growth YoY 11.90%

Balance Sheet

Total Cash MRQ $1,383,847,936
Total Cash per Share MRQ $9.48
Total Debt MRQ $
Total Debt to Equity MRQ 13.83
Current Ratio MRQ 2.89
Book Value per Share MRQ $41.94

Cash Flow

Operating Cash Flow TTM $1,883,371,008
Levered Free Cash Flow TTM $1,379,738,112

RMD Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 145,941,169
Float Shares 145,052,545
Avg 10 Volume 906,750
Avg 30 Volume None
Shares Short 10,557,741
Short Ratio 11.59
Short % of Shares 8.33%
% Held by Insiders 0.62%
% Held by Institutions 65.63%

Stock Price Summary

Beta 0.87
Fifty Two Week Low $199.92
Fifty Two Week High $293.81
Fifty Two Week Change 3.97%
Day 50 MA $251.05
Day 200 MA $254.19

Dividends and Splits

Forward Annual Dividend Rate $2.40
Forward Annual Dividend Yield 0.98%
Trailing Annual Dividend Rate $2.26
Trailing Annual Dividend Yield 0.92%
Payout Ratio 22.42%
Dividend Date 2025-12-18
Ex Dividend Date 2025-11-13
Last Split Factor
Last Split Date 2010-08-31